XML 94 R73.htm IDEA: XBRL DOCUMENT v3.22.4
Equity (Narrative) (Details)
₪ / shares in Units, $ / shares in Units, $ in Thousands
1 Months Ended 12 Months Ended
Dec. 20, 2022
₪ / shares
shares
Sep. 26, 2022
USD ($)
$ / shares
shares
Mar. 22, 2022
USD ($)
Mar. 07, 2022
USD ($)
$ / shares
shares
Oct. 06, 2021
shares
Sep. 28, 2022
USD ($)
Dec. 31, 2022
USD ($)
shares
Dec. 31, 2021
USD ($)
shares
Dec. 31, 2020
USD ($)
shares
Dec. 31, 2022
₪ / shares
Dec. 31, 2022
USD ($)
$ / shares
shares
Dec. 19, 2022
₪ / shares
shares
Nov. 28, 2022
ILS (₪)
₪ / shares
shares
Nov. 27, 2022
ILS (₪)
₪ / shares
shares
Oct. 06, 2022
$ / shares
Dec. 31, 2021
₪ / shares
shares
Disclosure of classes of share capital [line items]                                
Additional ordinary shares issued upon vesting of outstanding RSU's             11,827 4,852 4,852              
Authorized share capital | ₪                         ₪ 900,000 ₪ 500,000    
Number of shares authorised 12,857,143                   12,857,143 [1] 90,000,000 90,000,000 50,000,000   7,142,858
Ordinary shares, par value | ₪ / shares ₪ 0.07                 ₪ 0.01   ₪ 0.01 ₪ 0.01 ₪ 0.01   ₪ 0.01
Reverse stock split ratio 1-for-7 ratio           1-for-7 ratio                  
Number of common shares issued   1,082,223   744,048                        
Price per common shares issued | $ / shares       $ 13.44                        
Proceeds from shares issued | $     $ 8,653       $ 38,380 $ 0 $ 0              
Amount of underwriting discounts and commissions | $       $ 1,021                        
Exercised options to purchase additional ordinary shares       89,012                        
Aggregate amount of registered direct offering | $   $ 13,257                            
Purchase price of registered direct offering | $ / shares   $ 12.25                            
Number of warrants issued   1,082,223         124,491                  
Exercise price of warrants | $ / shares   $ 13.475                 $ 15.312          
Warrants expiration period   4 years                            
Net proceeds from offering amount | $           $ 11,698                    
Risk free interest rate of warrants             4.37%                  
Average standard deviation of warrants             68.00%                  
Unregistered pre funded warrants issued             1,407,583                  
Proceeds from warrants | $             $ 10 $ 0 $ 0              
Warrants to purchase ordinary Shares             124,491                  
Private Issuance Purchase Equity Agreement [Member]                                
Disclosure of classes of share capital [line items]                                
Proceeds from shares issued | $             $ 15,920                  
Number of warrants issued         1,407,583                      
Exercise price of warrants | $ / shares                             $ 13.475  
Risk free interest rate of warrants             4.26%                  
Unregistered pre funded warrants issued         1,407,583                      
Unregistered pre funded warrants to purchase common Stock         1,407,583                      
Increase in pre funded warrants exercise price | $ / shares                             $ 0.007  
Financial liabilities, at fair value | $                     $ 20,788          
Proceeds from warrants | $             $ 17,233                  
Loss from warrants transactions | $                     $ 3,555          
Warrants to purchase ordinary Shares         1,407,583                      
Certain entities affiliated with CBI [Member]                                
Disclosure of classes of share capital [line items]                                
Number of common shares issued       208,334                        
[1] Restated to reflect 1:7 reverse ratio of shares (See note 18b)